Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Hematopoietic Growth Factors In Aplastic Anemia Patients Treated with Immunosuppressive Therapy: Systematic Review and Meta-Analysis - 2010 Update.

Ronit Gurion, Anat Gafter-Gvili, MD, Liat Vidal, Mical Paul, Isaac Ben-Bassat, MD, Moshe Yeshurun, MD, Ofer Shpilberg, MD, MPH, Pia Raanani, MD

Blood (2010) 116 (21): 1164.

https://doi.org/10.1182/blood.V116.21.1164.1164

Published: 2010

Journal Articles

Myeloid Colony-Stimulating Factors Do Not Increase the Risk of Mortality or Disease Activity Measures in Patients with Acute Myeloid Leukemia: Systematic Review and Meta-Analysis.

Ronit Gurion, MD, Yulia Belnik-Plitman, MD, Anat Gafter-Gvili, MD, Mical Paul, MD, Liat Vidal, MD, Isaac Ben-Bassat, MD, Ofer Shpilberg, MD, MPH, Pia Raanani, MD

Blood (2009) 114 (22): 2045.

https://doi.org/10.1182/blood.V114.22.2045.2045

Published: 2009

Journal Articles

Management of Adult Patients with Acute Lymphoblastic Leukemia in First Complete Remission: Systematic Review and Meta-Analysis.

Ron Ram, MD, Anat Gafter-Gvili, MD, Liat Vidal, MD, Mical Paul, MD, Isaac Ben-Bassat, MD, Ofer Shpilberg, MD, MPH, Pia Raanani, MD

Blood (2009) 114 (22): 49.

https://doi.org/10.1182/blood.V114.22.49.49

Published: 2009

Journal Articles

Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan.

Abraham Avigdor, MD, Shlomo Bulvik, MD, Eldad Dann, MD, Itai Levi, MD, Galit Perez-Avraham, MD, Noga Shemtov, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Isaac Ben-Bassat, MD, Aaron Polliack, MD

Blood (2007) 110 (11): 2319.

https://doi.org/10.1182/blood.V110.11.2319.2319

Published: 2007

Journal Articles

Immunoglobulin Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation - Systematic Review and Meta-Analysis.

Pia Raanani, MD, Anat Gafter-Gvili, MD, Mical Paul, MD, Isaac Ben-Bassat, MD, Leonard Leibovici, MD, Shpilberg Ofer, MD

Blood (2007) 110 (11): 4962.

https://doi.org/10.1182/blood.V110.11.4962.4962

Published: 2007

Journal Articles

Combination of Rituximab with Initial Chemotherapy Improves Outcome of Primary Mediastinal B-Cell Lymphoma: A Retrospective Analysis of a Single Institution Cohort

Abraham Avigdor, MD, Tsvi Sirotkin, Noga Shemtov, MD, Miriam Berkowicz, MD, Yaron Davidovitz, MD, Abraham Kneller, MD, Izhar Hardan, MD, Avichai Shimoni, MD, Sara Apter, MD, Isaac Ben-Bassat, MD, Arnon Nagler

Blood (2007) 110 (11): 1283.

https://doi.org/10.1182/blood.V110.11.1283.1283

Published: 2007

Journal Articles

Ibritumomab Tiuxetan (Zevalin) Followed by High-Dose Chemotherapy and Autologous Stem-Cell Transplantation Results in Improved Survival of Patients with Chemo-Refractory Non-Hodgkin’s Lymphoma Expected To Have Poor Outcome with Standard Pre-Transplant Conditioning.

Avichai Shimoni, MD, Tsila Zwass, MD, Yaacov Oksman, MD, Izhar Hardan, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Abraham Avigdor, MD, Isaac Ben-Bassat, MD, Arnon Nagler, MD

Blood (2006) 108 (11): 3052.

https://doi.org/10.1182/blood.V108.11.3052.3052

Published: 2006

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation in AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: The Role of Dose-Intensity.

Avichai Shimoni, MD, Izhar Hardan, MD, Noga Shem-Tov, MD, Moshe Yeshurun, MD, Ronit Yerushalmi, MD, Isaac Ben-Bassat, MD, Arnon Nagler, MD

Blood (2005) 106 (11): 47.

https://doi.org/10.1182/blood.V106.11.47.47

Published: 2005

Journal Articles

Allogeneic Stem-Cell Transplantation in Patients with AML and MDS Using Myeloablative Versus Reduced-Intensity Doses of Intravenous Busulfan : The Role of Dose Intensity.

Avichai Shimoni, MD, Moshe Yeshurun, MD, Izhar Hardan, MD, Abraham Avigdor, MD, Noga Shem-Tov, MD, Isaac Ben-Bassat, MD, Arnon Nagler, MD

Blood (2004) 104 (11): 2308.

https://doi.org/10.1182/blood.V104.11.2308.2308

Published: 2004

Journal Articles

A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group.

Abraham Avigdor, MD, Shlomo Bulvik, MD, Noga Shemtov, MD, Itai Levi, MD, Miriam Berkowicz, MD, Dina Ben-Yehuda, MD, Dorit Blickstein, MD, Neta Goldschmidt, MD, Alexander Gural, MD, Abraham Kornberg, MD, Dianna Libster, MD, Drorit Merkel, MD, Elizabeth Naparstek, MD, Pia Raanani, MD, Batia Roth, MD, Yulia Volchek, MD, Arnon Nagler, MD, Isaac Ben-Bassat, MD, Aaron Polliack, MD

Blood (2004) 104 (11): 4576.

https://doi.org/10.1182/blood.V104.11.4576.4576

Published: 2004

NARROW

Hematopoietic Growth Factors In Aplastic Anemia Patients Treated with Immunosuppressive Therapy: Systematic Review and Meta-Analysis - 2010 Update.

Myeloid Colony-Stimulating Factors Do Not Increase the Risk of Mortality or Disease Activity Measures in Patients with Acute Myeloid Leukemia: Systematic Review and Meta-Analysis.

Management of Adult Patients with Acute Lymphoblastic Leukemia in First Complete Remission: Systematic Review and Meta-Analysis.

Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan.

Immunoglobulin Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation - Systematic Review and Meta-Analysis.

Combination of Rituximab with Initial Chemotherapy Improves Outcome of Primary Mediastinal B-Cell Lymphoma: A Retrospective Analysis of a Single Institution Cohort

Ibritumomab Tiuxetan (Zevalin) Followed by High-Dose Chemotherapy and Autologous Stem-Cell Transplantation Results in Improved Survival of Patients with Chemo-Refractory Non-Hodgkin’s Lymphoma Expected To Have Poor Outcome with Standard Pre-Transplant Conditioning.

Allogeneic Hematopoietic Stem-Cell Transplantation in AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: The Role of Dose-Intensity.

Allogeneic Stem-Cell Transplantation in Patients with AML and MDS Using Myeloablative Versus Reduced-Intensity Doses of Intravenous Busulfan : The Role of Dose Intensity.

A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only